Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Bilastine 20 mg tablets vs Bilaxten 20 mg tablets in healthy Thai volunteers under fasting conditions
TCTR20230504004Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bilastine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
bilastine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20230504004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230504004.